Speaker: P. Hemachandra Reddy, PhD – Tenured Professor and Vice Chair of Basic and Translational Research, Texas Tech University Health Sciences Center, Lubbock
Noon to 1 p.m.
Tuesday, November 16, 2021
This is a virtual seminar via Zoom. Please register and access information will be sent to your email before the event.
Alzheimer’s disease (AD) is a progressive mental illness, characterized by memory loss and multiple cognitive impairments with no cure. Currently, we do not have early detectable biomarkers and/or drugs that can delay progression of disease. Several years of research have revealed that physical inactivity and unhealthy diets largely involved in disease process. Dr. Reddy’s presentation will cover the global impact of dementia, causal factors of disease, research developments on cellular, molecular and pathological changes in disease process. Most importantly, his presentation will explain the impact of healthy aging and healthy lifestyle in delaying disease progression. Healthy aging and healthy lifestyle will help us to maintain both physical and mental health in our older age.
About the Speaker
Dr. Reddy is a tenured Professor and Vice Chair of Basic and Translational Research for the Department of Internal Medicine at Texas Tech University Health Sciences Center in Lubbock. Dr. Reddy is also a Professor of Neuroscience/Pharmacology, Neurology, Public Health and Speech, Language and Hearing Departments at Texas Tech. His research lab has been involved with research on healthy aging, dementia and other neurodegenerative diseases, including Huntington’s, Parkinson’s, and Multiple Sclerosis. In addition, the Reddy lab group is actively working on chronic conditions such as diabetes, obesity, cardiovascular, kidney, stroke, vascular dementia and other factors associated with dementia. Dr. Reddy is a prolific writer, author or co-author of more than 200 peer-reviewed articles/chapters/reviews, including publications in such journals as Nature Genetics, Ageing Research Reviews, Trends in Neurosciences, Trends in Molecular Medicine, Drug Discovery Today and Human Molecular Genetics. He has received research funding from the National Institutes of Health since 2002. He also serves as Chief Scientific Officer for the Lubbock-based small business company, abSynapTEX, LLC.
For more information:
please visit the event page on the NextGen Precision Health website.
The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities.
For questions about this event or any others in the Discovery Series, please reach out to Mary Hindle at hindlem@health.missouri.edu